Evaluation of a Standardized Treatment Regimen for Antibody Mediated Rejection Following Lung Transplantation
Richard W. Lincoln,
Elizabeth Hipkiss,
Keith A. Fester,
Sahil Sanghani,
Chad A. Witt,
Spenser January Clinical Transplantation
· Wiley
· 2026-11-01
· DOI: 10.1111/ctr.70737
The publisher did not provide an abstract — full text is available via the link below.
Richard W. Lincoln, Elizabeth Hipkiss, Keith A. Fester, Sahil Sanghani, Chad A. Witt, Spenser January. Evaluation of a Standardized Treatment Regimen for Antibody Mediated Rejection Following Lung Transplantation. // Clinical Transplantation. – 2026. – DOI: 10.1111/ctr.70737. – URL: https://onlinelibrary.wiley.com/doi/10.1111/ctr.70737?af=R
Richard W. Lincoln, Elizabeth Hipkiss, Keith A. Fester, Sahil Sanghani, Chad A. Witt, & Spenser January (2026). Evaluation of a Standardized Treatment Regimen for Antibody Mediated Rejection Following Lung Transplantation. Clinical Transplantation. https://doi.org/10.1111/ctr.70737
Richard W. Lincoln, et al. “Evaluation of a Standardized Treatment Regimen for Antibody Mediated Rejection Following Lung Transplantation.” Clinical Transplantation, 2026. doi:10.1111/ctr.70737.
@article{Lincoln2026,
title = {Evaluation of a Standardized Treatment Regimen for Antibody Mediated Rejection Following Lung Transplantation},
author = {Lincoln, Richard W. and Hipkiss, Elizabeth and Fester, Keith A. and Sanghani, Sahil and Witt, Chad A. and January, Spenser},
journal = {Clinical Transplantation},
year = {2026},
doi = {10.1111/ctr.70737},
url = {https://onlinelibrary.wiley.com/doi/10.1111/ctr.70737?af=R}
}